Pharmacology Watch – March 1, 2018
March 1, 2018
View Archives Issues
A once-promising drug produces disappointing results in a recent trial, to the dismay of researchers, patients, and families still searching for a cure.
The authors of a recent meta-analysis concluded that omega-3 fatty acids produced no effects on fatal or nonfatal coronary heart disease, nor on any major vascular events.
Researchers compared terbinafine to placebo and other oral antifungals, including the azole antifungals (ketoconazole, itraconazole, and fluconazole) and Griseofulvin.
In this section: The agency tackles loperamide abuse, approves new breast cancer treatment, updates guidance on opioid cough and cold medications, promotes new opportunities to battle the opioid epidemic, and issues new indication for an irritable bowel drug.